Global decentralized studies will become a standard clinical trial design approach
The Pharma Data
MARCH 20, 2021
“These focus areas will materialize in study designs as hybrid decentralized approaches that support global programs,” Reites said. “In In 2021, technology-enabled clinical research with a more global focus will become a standard clinical design approach.”. Source link: [link].
Let's personalize your content